Heart protein study pulled before starting
NCT ID NCT05830760
First seen Jan 08, 2026 · Last updated Apr 30, 2026 · Updated 17 times
Summary
This study was designed to measure a protein called SGLT2 in small heart tissue samples taken during aortic valve replacement surgery. Researchers wanted to compare levels between patients with and without diastolic heart failure to understand how certain diabetes drugs (gliflozines) might help the heart. The study was withdrawn before enrolling any participants, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67098, France
Conditions
Explore the condition pages connected to this study.